Richard Ulevitch - Del Mar CA Peter Tobias - Encinitas CA Samuel D. Wright - New York NY John C. Mathison - San Diego CA
Assignee:
The Sripps Research Institute - La Jolla CA The Rockefeller University - New York NY
International Classification:
G01N 3353
US Classification:
435 72, 435 29, 435334
Abstract:
The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
Methods And Compositions For Ameliorating The Symptoms Of Sepsis
Richard Ulevitch - Del Mar CA Peter Tobias - Encinitas CA Samuel D. Wright - New York NY John C. Mathison - San Diego CA
Assignee:
The Scripps Research Institute - La Jolla CA
International Classification:
G01N 3353 C12N 506 A61K 39395 C07K 1600
US Classification:
435335
Abstract:
The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
Methods And Compositions For Ameliorating The Symptoms Of Sepsis
Richard Ulevitch - Del Mar CA Peter Tobias - Encinitas CA Samuel D. Wright - New York NY John C. Mathison - San Diego CA
Assignee:
The Scripps Research Institute - La Jolla CA
International Classification:
C07K 1600 C07K 1618 A61K 37395 C12P 2108
US Classification:
4241541
Abstract:
The present invention concerns a method of treating CD14-mediated host inflammatory response to LPS often associated with sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
Methods And Compositions For Ameliorating The Symptoms Of Sepsis
Richard Ulevitch - Del Mar CA Peter Tobias - Encinitas CA Samuel D. Wright - New York NY John C. Mathison - San Diego CA
Assignee:
The Scripps Research Institute - La Jolla CA
International Classification:
A61K 39395
US Classification:
4241541
Abstract:
The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CDl4 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
Name / Title
Company / Classification
Phones & Addresses
Samuel Wright Principal
Wright Haus Business Services
2911 State St, Carlsbad, CA 92008
Samuel Wright Manager
Arkansas Department of National Guard National Security · National Guard Museum
Rancho Santa MargaritaI am a private pilot, love War Birds of WWII, fly model warbirds with radio control. i fly as often as there is a seat in a friend's warbird. Currently... I am a private pilot, love War Birds of WWII, fly model warbirds with radio control. i fly as often as there is a seat in a friend's warbird. Currently restoring a 1941 N2S-3 Stearman trainer.